GlassScriptPhysician profile
Allison Cavazos
NPI 1427491497
$1,841.46
in general payments reported to CMS, 2019-2025
19 companies · $41.78 in 2025
The $41.78 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $339 · 2021: $315 · 2022: $388 · 2023: $236 · 2024: $208 · 2025: $41.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.64 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.93 | 2019-2024 | Liletta, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $257.01 | 2022-2025 | |
| Therapeuticsmd, INC. | $203.56 | 2019-2022 | |
| Lupin INC. | $96.69 | 2019-2021 | |
| Intuitive Surgical, INC. | $92.92 | 2021-2022 | |
| Millicent US INC | $86.43 | 2024 | Intrarosa, Femring |
| Allergan, INC. | $77.48 | 2019 | |
| Vertical Pharmaceuticals, LLC | $64.75 | 2019 | |
| Exeltis, USA INC. | $59.60 | 2020-2023 | Slynd |
| Organon LLC | $55.84 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $44.48 | 2019-2020 | |
| Myovant Sciences INC. | $42.29 | 2021 | |
| Coopersurgical, INC. | $31.64 | 2021-2023 | Endosee |
| Astellas Pharma US INC | $22.86 | 2023 | Veozah |
| Mylan Pharmaceuticals INC. | $19.31 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.86 | 2023 | Cologuard Collection Kit |
| Minerva Surgical, INC | $16.78 | 2021 | |
| Duchesnay USA Incorporated | $15.07 | 2019 | |
| Pfizer INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Cavazos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.